Precision Medicine Market Forecast PowerPoint PPT Presentations

Global Precision Medicine Market Report 2020 - Market Size, Share, Price, Trend and Forecast is a professional and in-depth study on the current state of the global Precision Medicine industry.

Precision Medicine Market size is $113.76Bn in 2019, growing at a CAGR of 13.2% during the forecast period 2020-2025. Precision medicine is also called personalized medicine or individualized medicine is an approach that protects health and treat diseases taking into account an individual variability in genes, environment and lifestyle for every individual.

Precision Medicine Market size is $113.76Bn in 2019, growing at a CAGR of 13.2% during the forecast period 2020-2025. Precision medicine is also called personalized medicine or individualized medicine is an approach that protects health and treat diseases taking into account an individual variability in genes, environment and lifestyle for every individual.

Global artificial intelligence (ai) in precision medicine market size is expected to reach $6.86 Bn by 2028 at a rate of 30.4%, segmented as by component, hardware, software, service

Global artificial intelligence (ai) in precision medicine market size is expected at $5.22 Bn by 2027 at a growth rate of 30.1%.

The major players in the precision medicine market are Qiagen, Novartis AG, Medtronic, AstraZeneca plc., Quest Diagnostics, Thermo Fisher Scientific Inc...@@ https://bit.ly/2XCz1CE

The latest report published by Persistence Market Research titled “Global Market Study on Precision Medicine: Drug Discovery Technology Segment Estimated to Witness 0.1% Decline in Market Share Between 2016 and 2024“. projects some of the crucial aspects of the global precision medicine market after an in-depth research. The report assures that the market will grow manifold and it will register a 14.7% CAGR between 2016 and 2024.

Precision Medicine Market size was over USD 39 billion in 2015, and is anticipated to grow at 10.5% CAGR from 2016 to 2023. Get more details @ https://goo.gl/y9VxzK

This report focuses on the global Precision Medicine Diagnostics status, future forecast, growth opportunity, key market and key players.

This report focuses on the global Precision Medicine Software status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Precision Medicine Software development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

Global Precision medicine Market Information by Ecosystem (diagnostic companies, clinical laboratories), by Sub Markets (Companion diagnostic, biomarker based test), by Therapeutics (cardiovascular disease, central nervous system) - Forecast to 2027

Get more details @ http://bit.ly/2ekRPfD Key industry players contributing to global precision medicine market share include Pfizer, Roche, Covance, Novartis, Qiagen, Biocrates Life Sciences, Teva Pharmaceutical, Nanostring Technologies, Laboratory Corporation of America Holdings, Tepnel Pharma Services, Intomics, Ferrer InCode, Silicon Biosystems, Eagle Genomics, Medtronic, and Quest Diagnostics.

The global oncology precision medicine market was estimated to be worth $49.4 billion in 2021, and it is expected to reach $ 124.84 billion by 2030, expanding at a CAGR of 10.85% from 2021 to 2030 For more info - https://straitsresearch.com/report/oncology-precision-medicine-market

According to the latest research report by IMARC Group, The United States precision medicine market size is projected to exhibit a growth rate (CAGR) of 7.10% during 2024-2032. More Info:- https://www.imarcgroup.com/united-states-precision-medicine-market

The Global Precision Medicine Market is expected to register 12.48% CAGR and is anticipated to reach USD 126.14 Billion by 2025

The report Personalized Medicine Market analyzes the Market status, Market share, growth rate, future trends, Market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

AI in Precision Medicine Market by Offering (Hardware, Software, Services), Technology (Machine Learning, Natural Language Processing, Context-aware Computing, Computer Vision), Therapeutic Application (Oncology, Cardiology, Neurology, Respiratory, Others), and Region (North America, Europe, Asia Pacific, RoW) – Global Forecast to 2027

The Veterinary Medicine Market Report provides an exhaustive analysis of the growth drivers, current trends, restraining forces, and opportunities present in the market.

According to P&S Intelligence, the precision medicine market generated $203.5 billion in 2019 and it is expected to reach $738.8 billion by 2030, progressing at a CAGR of 12.1% during the forecast period (2020–2030). This growth can be driven by the rising government support, escalating awareness regarding personalized treatments, rising number of approved personalized medications, increasing use of artificial intelligence (AI) in clinical trials related to precision medications, surging number of regulatory approvals, soaring cases of chronic and genetic diseases, and flourishing medical tourism industry.

Read here the latest updates on the Cell Surface Markers Market published by CMI team.

The global artificial intelligence (AI) in precision medicine market is expected to grow from $1.41 billion in 2022 to $1.82 billion in 2023 at a compound annual growth rate (CAGR) of 29.3%.

Request for sample research report at https://precisionbusinessinsights.com/request-sample?product_id=17135 The global regenerative medicine market size was valued US$ 8425 Mn in the year 2020 and is anticipated to grow at US$ 21871 Mn till 2027 witnessing a CAGR of 14.6% over the forecast period 2021-2027. Market players took initiatives for increasing finance for R&D of regenerative medicine is projected to support the market growth. Furthermore industries are working together to reinforce their R&D capabilities for the developing as well as commercializing pioneering therapies for making

DecisionDatabases.com, a market research firm adds a report Global Computational Medicine Industry 2016 Market Research Report to its repository. The report gives a detailed account of the industry - Sales, Revenue Size, Share, Exports, Imports, and Production Volume etc.

Non-Oncology Precision Medicine market is segmented by Ecosystem, and by Application. Players, stakeholders, and other participants in the global Non-Oncology Precision Medicine market will be able to gain the upper hand as they use the report as a powerful resource.

The global precision medicine market is expected to grow from $62.75 billion in 2020 to $72.58 billion in 2021 at a compound annual growth rate (CAGR) of 15.7%.

Get more details @ http://bit.ly/2l3rNQ4 Key industry players contributing to global precision medicine market share include Pfizer, Roche, Covance, Novartis, Qiagen, Biocrates Life Sciences, Teva Pharmaceutical, Nanostring Technologies, Laboratory Corporation of America Holdings, Tepnel Pharma Services, Intomics, Ferrer InCode, Silicon Biosystems, Eagle Genomics, Medtronic, and Quest Diagnostics

The global companion diagnostics market is anticipated to grow at a CAGR of 13.29%, and is estimated to reach $15441.90 million by 2030. Get Free Sample Report.

The latest report published by Persistence Market Research titled “Global Market Study on Precision Medicine: Drug Discovery Technology Segment Estimated to Witness 0.1% Decline in Market Share Between 2016 and 2024“. projects some of the crucial aspects of the global precision medicine market after an in-depth research. The report assures that the market will grow manifold and it will register a 14.7% CAGR between 2016 and 2024.

Get more details @ http://bit.ly/2ekRPfD Some of the major players of global precision medicine market are Intomics, F. Hoffmann-La Roche, NanoString Technologies, Laboratory Corporation of America Holdings, Biocrates Life Sciences, Teva Pharmaceutical, Tepnel Pharma Services, Novartis, Silicon Biosystems, Quest Diagnostics and Ferrer InCode.

Get more details @ http://bit.ly/2ekRPfD Some of the major players of global precision medicine market are Intomics, F. Hoffmann-La Roche, NanoString Technologies, Laboratory Corporation of America Holdings, Biocrates Life Sciences, Teva Pharmaceutical, Tepnel Pharma Services, Novartis, Silicon Biosystems, Quest Diagnostics and Ferrer InCode.

The global Bioinformatics Market is primarily driven by the increasing adoption of next-generation sequencing (NGS) technologies and rising focus on precision medicine.

The Global Precision Oncology market research report provides an insightful analysis of the current market, along with a futuristic perspective on the growth of the market.

The report assures that the market will grow manifold and it will register a 14.7% CAGR between 2016 and 2024.

According to Market Research Future (MRFR) Analysis – US Personalized Medicine Market is growing at a CAGR of 7.5% during the forecast period of 2017 to 2023. The research report includes Industry updates, size, share, demand analysis, competitive landscape, market attractiveness

Electroceuticals/Bioelectric Medicine Market is expected to grow in upcoming years due to factors such as rise in geriatric population across the world, increase in regulatory approvals for new and advanced electroceuticals and rise in investment and funds for the development in new therapies.

The latest report by Precision Business Insights, titled “Personalized Medicine Market” covers complete information on market size, share, growth, trends, segment analysis, key players, drivers, and restraints.

The global saffron market size reached US$ 518.4 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,017.8 Million by 2032, exhibiting a growth rate (CAGR) of 7.76% during 2024-2032.

Precision Oncology Market

The global medical dynamometer market is predicted to grow at a CAGR of 5.76% over the forecast period of 2024 to 2032. Get more insights into our latest blog

The global dermatology diagnostic devices market size reached US$ 16.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 34.4 Billion by 2032, exhibiting a growth rate (CAGR) of 8.6% during 2024-2032.

According to the latest research report by IMARC Group, The United States digital PCR market size reached US$ 1.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.0 Billion by 2032, exhibiting a growth rate (CAGR) of 22.20% during 2024-2032. More Info:- https://www.imarcgroup.com/united-states-digital-pcr-market

The global Radiopharmaceuticals/Nuclear Medicine Market was valued at US$ 5605 Million in 2022 and is anticipated to grow at US$ 9327 Million by 2029 recording a CAGR of 9.3% during the forecast period 2023-2029. Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=17441

The Global Cancer Profiling Market size is estimated to grow at a CAGR of around 11.5% during the forecast period, i.e., 2024-30.

Global Market Insights add New Global Mice Model Market report provides in-depth information about market overview, top vendors, Key market highlights, product types, market drivers, challenges, trends, industry landscape, size and forecast, five forces analysis, Key leading countries/Region.

The global precision medicine market is expected to reach $278.61 billion by the end of 2030. The market is projected to grow at a CAGR of 11.13% during the forecast period, 2020-2030. Factors driving the growth of the market including advancement of sequencing technologies, rising prevalence of chronic diseases, growing demand for preventive care, and shifting the significance in medicine from reaction to prevention.

The drone logistics and transportation market is projected to grow from USD 534 million in 2022 to USD 17,881 million by 2030, at a CAGR of 55.1% from 2022 to 2030.

The global Process Analyzer market is expected to grow from USD 7.8 billion in 2023 to USD 9.3 billion by 2028, registering a CAGR of 3.6%. The demand for exceptionally precise process analyzers is escalating within the expanding domains of drug development, bioprocessing, and personalized medicine. These analytical instruments are indispensable in research, development, and pharmaceutical manufacturing, guaranteeing the highest levels of quality. Browse 120 market data Tables and 40 Figures spread through 200 Pages and in-depth TOC on "Process Analyzer Market - Global Forecast to 2028"

Global Market Insights Inc. presents the Mice Model Market provides a detailed overview of major drivers, restraints, challenges, opportunities, current industry trends and strategies impacting the global market along with estimates and forecast of revenue.

The rising prevalence of Leukemia and Multiple myeloma and the increasing awareness among patients and healthcare professionals about initial diagnosis are driving the demand for the market.

The global companion diagnostics market is anticipated to grow at a CAGR of 13.29%, and is estimated to reach $15441.90 million by 2030. Get Free Sample Report.

According to the latest research report by IMARC Group, The global genotyping market reached a value of US$ 14.77 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 36.75 Billion by 2027, exhibiting a CAGR of 15.60% during 2022-2027. More Info:- https://www.imarcgroup.com/genotyping-market

The global smart irrigation market size reached USD 1,476.3 Million in 2021 and is expected to register a revenue CAGR of 15.2% during the forecast period, according to latest analysis by Emergen Research. Increasing development of smart cities and increasing need to save water and reduce related expenses are key factors projected to support market revenue growth between 2022 and 2030.

The research firm Contrive Datum Insights has just recently added to its database a report with the heading global Alternative Medicines and Therapies Market .Both primary and secondary research methodologies have been utilised in order to conduct an analysis of the worldwide Alternative Medicines and Therapies Market . In order to provide a comprehensive comprehension of the topic at hand, it has been summed up using appropriate and accurate market insights. According to Contrive Datum Insights, this worldwide comprehensive report is broken up into several categories in order to present the data in a way that is understandable, succinct, and presented in a professional manner.Natural treatments that are different from traditional medications or drugs are referred to as alternative medicine and therapies. A variety of natural and non-mineral, non-vitamin, and alternative medicine therapies are available.

The Global Topical Dispenser Market was evaluated at USD 418 billion in 2019 and is anticipated to reach USD 631.8 billion by 2027, at a CAGR of 5.3 % during the projection period.

According to Renub Research analysis Global Molecular Diagnostics Market is likely to surpass US$ 22.5 Billion by the end of year 2025. By Application (2019 - 2025). Access full Research: https://www.renub.com/global-molecular-diagnostics-market-and-future-forecast-2010-2014-334-p.php

The exosome diagnostic and therapeutic market was valued at US$ 41.6.33 million in 2019 and is expected to grow at a CAGR of 32.2% from 2020 to 2027 to reach US$ 358.91 million 2027.